Common weight loss medication successfully targets the type of fat that may jeopardize heart health
UT Southwestern researchers announced successful results of a clinical trial for a commonly prescribed weight loss drug called liraglutide. In overweight or obese adults who also had a high cardiovascular risk, liraglutide once a day, combined with lifestyle interventions significantly reduced two types of fat that have been associated with heart health risk: visceral fat…